Free Trial

CIBC Private Wealth Group LLC Has $48.04 Million Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background
Remove Ads

CIBC Private Wealth Group LLC increased its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 6,911.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 785,928 shares of the company's stock after buying an additional 774,718 shares during the quarter. CIBC Private Wealth Group LLC owned about 0.30% of Ryan Specialty worth $48,036,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Rakuten Securities Inc. acquired a new position in Ryan Specialty in the fourth quarter worth approximately $27,000. Principal Securities Inc. grew its holdings in shares of Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after acquiring an additional 415 shares during the last quarter. Quarry LP raised its position in shares of Ryan Specialty by 109.3% during the third quarter. Quarry LP now owns 808 shares of the company's stock worth $54,000 after purchasing an additional 422 shares during the period. Harvest Fund Management Co. Ltd acquired a new position in shares of Ryan Specialty in the 4th quarter valued at $54,000. Finally, R Squared Ltd purchased a new position in Ryan Specialty in the 4th quarter worth about $92,000. Institutional investors own 84.82% of the company's stock.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the business's stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $65.99, for a total value of $2,309,650.00. Following the transaction, the director now directly owns 35,609 shares of the company's stock, valued at $2,349,837.91. This represents a 49.57 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 241,360 shares of company stock worth $16,006,428. 11.10% of the stock is owned by corporate insiders.

Remove Ads

Analysts Set New Price Targets

RYAN has been the topic of several analyst reports. Morgan Stanley began coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 target price on the stock. Keefe, Bruyette & Woods lowered their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating on the stock in a research report on Friday, February 21st. Wells Fargo & Company increased their target price on Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a report on Friday, February 21st. UBS Group lifted their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a report on Wednesday, February 26th. Finally, Royal Bank of Canada reduced their price objective on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. According to MarketBeat, Ryan Specialty has a consensus rating of "Hold" and an average price target of $75.27.

View Our Latest Analysis on RYAN

Ryan Specialty Stock Up 1.7 %

Shares of NYSE RYAN traded up $1.25 during trading hours on Thursday, hitting $76.31. The stock had a trading volume of 669,952 shares, compared to its average volume of 929,924. The company has a market capitalization of $19.98 billion, a P/E ratio of 110.65, a P/E/G ratio of 1.19 and a beta of 0.71. The firm's 50-day moving average price is $69.22 and its two-hundred day moving average price is $68.51. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a 52 week low of $48.48 and a 52 week high of $77.15.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. Analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a $0.12 dividend. The ex-dividend date was Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.63%. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's payout ratio is currently 69.57%.

Ryan Specialty Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Further Reading

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads